RAYMOR INDUSTRIES INC.

RAYMOR INDUSTRIES INC.

March 10, 2005 09:00 ET

Raymor Industries Begins Commercial Production of Nano-Sized and Micron-Sized Titanium Powder for the Biomedical and Aerospace Markets


NEWS RELEASE TRANSMITTED BY CCNMatthews

FOR: RAYMOR INDUSTRIES INC.

TSX VENTURE SYMBOL: RAR

MARCH 10, 2005 - 09:00 ET

Raymor Industries Begins Commercial Production of
Nano-Sized and Micron-Sized Titanium Powder for the
Biomedical and Aerospace Markets

MONTREAL, QUEBEC--(CCNMatthews - March 10, 2005) - Raymor Industries
(TSX VENTURE:RAR) is proud to announce that its wholly-owned, industrial
subsidiary, AP&C Advanced Powders and Coatings Inc. (AP&C) will begin
commercial production of nano-sized and micron-sized titanium powders,
in order to meet immediate demands for this high value-added product
with specific companies in the biomedical and aerospace sectors. AP&C
is currently negotiating with a major US enterprise involved in the
production and commercialization of biomedical products. This company
is considering the commercialization of a new generation of innovative
orthopedic implants produced using AP&C titanium powders. This US
company had received approval from the Food & Drug Administration (FDA)
for these productS manufactured using AP&C powders, which are produced
using a patented process. Commercial applications for these implants
can include hip and knee replacements, as well as other orthopedic
implants.

Engineering studies performed over the last two months with regards to
optimizing the capacity of the reactor have determined that AP&C will
attain an optimal production capacity after the first three months of
operation. At full capacity, revenues generated from the sale of
titanium powder over a 12 month timeframe will surpass $3.5 million per
reactor. AP&C powder production capacity will double with the
installation of a second reactor in the coming months. The
infrastructure is in place to build up to 6 reactors.

AP&C metal powders are produced using a unique, patented process,
developed over 14 years at a cost of over $10 million. This process,
developed in partnership with Hydro-Quebec, has been licensed to AP&C on
an exclusive, worldwide basis. The exceptional qualities of AP&C
powders are the sphericity and the purity obtained using the Plasma
Atomization Process. The flowability of AP&C powders, given its
spherical nature, allows for an evenly distributed coating on hip, knee
and other artificial joints. Also, the high purity and sphericity of
the powder provides components with an optimal porosity for encouraging
human tissue growth, thus offering enhanced biocompatibility properties.

With regards to the potential market for AP&C titanium powders, the
world market for orthopedic implants was more than US$6.4 billion in
2002. Analysts from the renowned Freedonia Group predict markets of
US$8.7 billion in 2007 and US$11.6 billion in 2012. The overall growth
rate for this sector will be 6.2%. However, Freedonia Group and Frost &
Sullivan both agree that this growth rate can increase significantly (up
to 15% per year), given the removal of certain anti-inflammatory and
pain medications from the market place by the FDA. As well, an aging
population will likely have an impact on the orthopedic implant market
growth rate.

"We believe that the unique properties of our nano-sized and
micron-sized metallic powders will allow AP&C to claim a significant
portion of the biomedical market," confirms Stephane Robert, President
of Raymor Industries & AP&C. "We also foresee the rapid
commercialization of our powders in other innovative sectors. Several
business opportunities in this area will be finalized shortly," added
Mr. Robert.

RAYMOR INDUSTRIES INC. (TSX-V:RAR) has for mission to be the largest
Canadian developer of high technology and a producer/recycler of
advanced materials and nanomaterials for high value-added applications.
In November 2004, Raymor Industries created an industrial subsidiary,
AP&C Advanced Powders and Coatings, specializing in nanotechnology and
advanced materials, and comprising four operational divisions: (1) metal
and ceramic coatings, which largely targets aerospace, military, and
mining applications; (2) spherical metallic powders, primarily used for
biomedical and aerospace applications; (3) nanotechnology products,
including nano-powders, nano-coatings, and carbon nanotubes for "the
applications of tomorrow"; and (4) net-shape forming, a component
manufacturing technique used for ballistic protection and other
aerospace and military applications. Raymor holds the exclusive rights
to 20 patents throughout the world.


ON BEHALF OF THE BOARD OF DIRECTORS

Stephane Robert, President.


FOR MORE INFORMATION ON NANOTECHNOLOGY AND ITS POTENTIAL, PLEASE VISIT
THE FOLLOWING SITE: www.nanoquebec.ca

-30-

Contact Information

  • FOR FURTHER INFORMATION PLEASE CONTACT:
    Raymor Industries Inc.
    Raymond Fournel
    Investor Relations
    (514) 932-3485
    (514) 932-3644 (FAX)
    investor@raymor.com
    www.raymor.com
    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this release.